Part,  Chapter, Paragraph

 1   II,     5.  5.  3|                not in remission had a 9.3 RR of death (95% CI 3.8-22.
 2   II,     5.  5.  3|    seizure-related accidents (rate ratio, RR 1.8)(Vaa, 2005) and the
 3   II,     5.  5.  3|                risk of serious accidents (RR 1.4)(Taylor et al, 1996)
 4   II,     5.  5.  3| secondary-progressive MS (SP-MS), initial RR course followed by progression
 5   II,     5.  5.  3|                  PR courses are lumped to RR or PP ones.~ ~Disability~
 6   II,     5.  8.Acr|                 RI~Respiratory Infections~RR~Relative Risk~VC~Vital Capacity~
 7   II,     5.  8.  3|                 pneumonia (relative risk (RR) = 16.0), osteoporosis (
 8   II,     5.  8.  3|                      16.0), osteoporosis (RR = 3.1), RI (RR = 2.2), MI (
 9   II,     5.  8.  3|              osteoporosis (RR = 3.1), RI (RR = 2.2), MI (RR = 1.7), angina (
10   II,     5.  8.  3|                  3.1), RI (RR = 2.2), MI (RR = 1.7), angina (RR = 1.7),
11   II,     5.  8.  3|                    MI (RR = 1.7), angina (RR = 1.7), fractures (RR =
12   II,     5.  8.  3|             angina (RR = 1.7), fractures (RR = 1.6), and glaucoma (RR =
13   II,     5.  8.  3|                  RR = 1.6), and glaucoma (RR = 1.3) [all p <0.05].~ ~
14   II,     5.  9. FB|                increase in relative risk (RR 1.5, 95% CI 1.2 to 1.8).
15   II,     5.  9. FB|            subsequent asthma had a pooled RR of 1.2 (95% CI 1.1 to 1.
16   II,     5.  9.  4|                   in 1989: relative risk (RR) 1.32 (1.12, 1.56), even
17   II,     5.  9.  4|                   eczema and/or hay fever RR 1.20 (0.99, 1.45). By 2004
18   II,     5.  9.  4|          diagnosis was no longer present, RR 1.01 (0.91, 1.12) for wheeze
19   II,     5.  9.  4|             products, or chemical spills (RR=3.3, 95% CI 1.0-11.1, P=